Kimberly-Clark to buy Kenvue in $48.7 billion deal


Huggies, manufactured by Kimberly-Clark and Band-Aid, manufactured by Kenvue.

Getty Images

Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant.

The deal is a combination of cash and stock. Shares of Kenvue surged 20% in premarket trading Monday, while shares of Kimberly-Clark plunged 14%.

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol. It would include 10 billion-dollar brands, the companies said in a news release. The acquisition would be one of the largest on Wall Street this year.

The transaction is expected to close in the second half of 2026.

Kimberly-Clark Chairman and CEO Mike Hsu said in a statement that the companies share a “commitment to developing science and technology to provide extraordinary care.”

“Over the last several years, Kimberly-Clark has undertaken a significant transformation to pivot our portfolio to higher-growth, higher-margin businesses while rewiring our organization to work smarter and faster,” Hsu said. “We have built the foundation and this transaction is a powerful next step in our journey.”

Kenvue, a portfolio of consumer health brands, spun out of Johnson & Johnson in May 2023. Since then, shares have fallen almost 35% from their initial public offering price. As of Friday’s close, Kenvue traded at about $14 per share for a market cap of roughly $27 billion.

Kenvue Chair Larry Merlo said in a statement that following a comprehensive strategic review, the board is “confident this combination represents the best path forward for our shareholders and all other stakeholders.”

Three Kenvue board members will join the Kimberly-Clark board upon the deal’s closing. Hsu will continue to serve as CEO.

The combined company would generate estimated 2025 annual net revenues of roughly $32 billion and adjusted EBITDA of approximately $7 billion, according to the release.

Kimberly-Clark and Kenvue expect about $1.9 billion in cost synergies from the transaction to be realized in the first three years following the deal’s close.


Related Posts

Novo Nordisk’s Wegovy pill launch draws new wave of patients to GLP-1s

After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t enough.”  Zuckerman, a 32-year-old data analyst based in Washington, D.C.,…

Iran war upends spring housing

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Why Mike Vrabel, Dianna Russini were ‘holding hands’ at a Sedona hotel. Truth behind cheating controversy

  • By admin
  • April 8, 2026
  • 0 views
Why Mike Vrabel, Dianna Russini were ‘holding hands’ at a Sedona hotel. Truth behind cheating controversy

Korean Stocks, Won Surge After Iran Ceasefire Brings Relief

  • By admin
  • April 8, 2026
  • 0 views
Korean Stocks, Won Surge After Iran Ceasefire Brings Relief

Novo Nordisk’s Wegovy pill launch draws new wave of patients to GLP-1s

  • By admin
  • April 8, 2026
  • 0 views
Novo Nordisk’s Wegovy pill launch draws new wave of patients to GLP-1s

Hardik Pandya ‘fascinated’, repeatedly pats Vaibhav Sooryavanshi following teenager’s 14-ball blitz in Guwahati

  • By admin
  • April 8, 2026
  • 1 views
Hardik Pandya ‘fascinated’, repeatedly pats Vaibhav Sooryavanshi following teenager’s 14-ball blitz in Guwahati

Candidates: Divya beats Anna, jumps into joint lead; Pragg loses

  • By admin
  • April 8, 2026
  • 3 views
Candidates: Divya beats Anna, jumps into joint lead; Pragg loses

iPhone Fold: Everything we know about Apple’s first foldable phone  | Technology News

  • By admin
  • April 8, 2026
  • 3 views
iPhone Fold: Everything we know about Apple’s first foldable phone  | Technology News